(Q29616236)
Statements
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer (English)
2 references
Armando Santoro
1 reference
Yves Humblet
David Khayat
Harry Bleiberg
Danny Bets
Matthias Mueser
Andreas Harstrick
Chris Verslype
Ian Chau
Eric Van Cutsem
2 references
351
2 references
4
2 references
Identifiers
3 references
3 references